As shown in Figure 4B, CpG oligonucleotides determined a 2.9-fold increase in metabolically active CLL cells when added alone and a 3.4-fold increase when used in combination with ET-1 (p<0.01 both, compared to cells cultured alone in medium). The gene discussed is EDN1; the disease is B-cell chronic lymphocytic leukemia.